Calcium tablets trial for PBSC collection

JRCT ID: jRCTs061220096

Registered date:09/02/2023

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: healthy donors
• Date of first enrollment: 07/07/2023
• Target sample size: 70
• Study type: Interventional
• Intervention(s): taking tablets before starting peripheral progenitor cell collection

Outcome(s)

• Primary Outcome: Incidence of citrate-related adverese effect; Grade 1 or higher

Secondary Outcome

Incidence of citrate-related adverese effect; Grade 2 or higher
Incidence of citrate-related adverese effect; Grade 3 or higher
Percentage decrease in ionized calcium, potassium, etc.
safety

Key inclusion & exclusion criteria

• Age minimum: >= 15age old
• Age maximum: <= 65age old
• Gender: Both
• Include criteria: healthy donors
• Exclude criteria: Those that do not meet the eligibility requirements to be a healthy donor

Related Information

• Primary Sponsor: Fujii Keiko